Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

Name: Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

sarcoma, wilm's tumor, lymphoma, neuroblastoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 154660
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.